Successful salvage of primary progressive Hodgkin lymphoma with the combination of post-transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition

Hematol Oncol. 2021 Apr;39(2):258-262. doi: 10.1002/hon.2801. Epub 2020 Sep 23.

Affiliations

¹ Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
² Department of Nuclear Medicine and PET/CT, Evangelismos General Hospital, Athens, Greece.

PMID: 32905619
DOI: 10.1002/hon.2801

No abstract available

Keywords: Hodgkin lymphoma; autologous transplantation; brentuximab vedotin; primary refractory; radiotherapy.

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Agents, Immunological / therapeutic use
Brentuximab Vedotin / therapeutic use*
Combined Modality Therapy
Female
Hodgkin Disease / pathology
Hodgkin Disease / therapy*
Humans
Male
Radiotherapy / methods*
Salvage Therapy*
Stem Cell Transplantation / methods*
Transplantation, Autologous
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
Brentuximab Vedotin